383 related articles for article (PubMed ID: 27249556)
21. Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy.
Francia P; Santini D; Musumeci B; Semprini L; Adduci C; Pagannone E; Proietti G; Volpe M; Autore C
J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1180-7. PubMed ID: 25066044
[TBL] [Abstract][Full Text] [Related]
22. Ventricular arrhythmias and left ventricular hypertrophy in hypertrophic cardiomyopathy.
Piva e Mattos B; Torres MA; Freitas VC; Scolari FL; Loreto MS
Arq Bras Cardiol; 2013 May; 100(5):452-9. PubMed ID: 23579622
[TBL] [Abstract][Full Text] [Related]
23. Burden of premature ventricular contractions beyond nonsustained ventricular tachycardia is related to the myocardial extracellular space expansion in patients with hypertrophic-cardiomyopathy.
Chung H; Park CH; Kim Y; Kim JY; Min PK; Yoon YW; Lee KA; Lee BK; Hong BK; Kim TH; Rim SJ; Kwon HM; Choi EY
Clin Cardiol; 2020 Nov; 43(11):1317-1325. PubMed ID: 32815161
[TBL] [Abstract][Full Text] [Related]
24. Reversed Septal Curvature Is Associated With Nonsustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy.
He Y; Zhou J
Am J Cardiol; 2024 Jan; 210():195-200. PubMed ID: 37884111
[TBL] [Abstract][Full Text] [Related]
25. [The relationship between QT dispersion and risk factors of sudden death in hypertrophic cardiomyopathy].
Göktekin O; Ritsushi K; Matsumoto K; Hiroshi M
Anadolu Kardiyol Derg; 2002 Sep; 2(3):226-30. PubMed ID: 12223331
[TBL] [Abstract][Full Text] [Related]
26. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the corrected QT before the onset of nonsustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
Baranowski R; Chojnowska L; Michalak E; Orłowska-Baranowska E
Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):387-9. PubMed ID: 12687851
[TBL] [Abstract][Full Text] [Related]
28. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.
Adabag AS; Maron BJ; Appelbaum E; Harrigan CJ; Buros JL; Gibson CM; Lesser JR; Hanna CA; Udelson JE; Manning WJ; Maron MS
J Am Coll Cardiol; 2008 Apr; 51(14):1369-74. PubMed ID: 18387438
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of 14-Day Holter for Detection of Nonsustained Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
Weissler-Snir A; Chan RH; Adler A; Care M; Chauhan V; Gollob MH; Ziv-Baran T; Fourey D; Hindieh W; Rakowski H; Spears DA
Am J Cardiol; 2016 Oct; 118(8):1258-1263. PubMed ID: 27567133
[TBL] [Abstract][Full Text] [Related]
30. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H
J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of T-wave alternans in hypertrophic cardiomyopathy.
Kuroda N; Ohnishi Y; Yoshida A; Kimura A; Yokoyama M
Circ J; 2002 May; 66(5):457-62. PubMed ID: 12030340
[TBL] [Abstract][Full Text] [Related]
32. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
[TBL] [Abstract][Full Text] [Related]
33. Cardiac troponin I is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.
Zhou Y; Yu M; Yuan J; Liu S; Hu F; Yang Z; Cui J; Qiao S
Heart Vessels; 2020 Jun; 35(6):876-885. PubMed ID: 31907598
[TBL] [Abstract][Full Text] [Related]
34. The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. A prospective study.
Saumarez RC; Slade AK; Grace AA; Sadoul N; Camm AJ; McKenna WJ
Circulation; 1995 Jun; 91(11):2762-8. PubMed ID: 7758182
[TBL] [Abstract][Full Text] [Related]
35. Nonsustained Ventricular Tachycardia Is Independently Associated With Sustained Ventricular Arrhythmias in Nonischemic Dilated Cardiomyopathy.
Piers SR; Androulakis AF; Yim KS; van Rein N; Venlet J; Kapel GF; Siebelink HM; Lamb HJ; Cannegieter SC; Man SC; Zeppenfeld K
Circ Arrhythm Electrophysiol; 2022 Feb; 15(2):e009979. PubMed ID: 35089806
[TBL] [Abstract][Full Text] [Related]
36. QT-interval abnormalities in hypertrophic cardiomyopathy.
Dritsas A; Sbarouni E; Gilligan D; Nihoyannopoulos P; Oakley CM
Clin Cardiol; 1992 Oct; 15(10):739-42. PubMed ID: 1395184
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with mild hypertrophic cardiomyopathy compared with power athletes.
D'Andrea A; Caso P; Cuomo S; Salerno G; Scarafile R; Mita C; De Corato G; Sarubbi B; Scherillo M; Calabrò R
Br J Sports Med; 2006 Mar; 40(3):244-50; discussion 244-50. PubMed ID: 16505082
[TBL] [Abstract][Full Text] [Related]
38. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
[TBL] [Abstract][Full Text] [Related]
39. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy.
Becker R; Haass M; Ick D; Krueger C; Bauer A; Senges-Becker JC; Voss F; Hilbel T; Niroomand F; Katus HA; Schoels W
Basic Res Cardiol; 2003 Jul; 98(4):259-66. PubMed ID: 12835955
[TBL] [Abstract][Full Text] [Related]
40. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
